Intellectual Property India Publishes Patent Application for 'Novel Process For The Preparation Of (4-Fluorophenyl)[(8r)-8-Methyl-3-(3-Methyl-1,2,4-Thiadiazol-5-Yl)-5,6-Dihydro[1,2,4]Triazolo[4,3- A]Pyrazin-7(8h)-Yl]Methanone And Its Intermediates Thereof' Filed by MSN Laboratories Private Limited, R&D Center

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202441005790 A) filed by MSN Laboratories Private Limited, R&D Center, Hyderabad, Telangana, on Jan. 29, 2024, for 'novel process for the preparation of (4-fluorophenyl)[(8r)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4]triazolo[4,3- a]pyrazin-7(8h)-yl]methanone and its intermediates thereof.'

Inventor(s) include Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Keshavareddy Navin Kumar Reddy; and Kootikanti Krishnaiah.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "Novel process for the preparation of (4-Fluorophenyl)[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H) -yl]methanone and its intermediates thereof The present invention provides a novel process for the preparation of (4-Fluorophenyl)[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4] triazolo [4,3-a]pyrazin-7(8H)-yl]methanone of formula-1 and its novel intermediates thereof. Formula-1."

Disclaimer: Curated by HT Syndication.